Name: GENEDX HOLDINGS CORP (WGS) Stock
Brand: GENEDX HOLDINGS CORP
Rating: 8 (3 reviews)

WGS Latest News, Press Relases and Analysis

All

Press Releases

2 days ago - By: The Motley Fool

GeneDX CEO Sells 2,158 Shares After 84% One-Year Bump

11 days ago - By: Halper Sadeh LLP

HALPER SADEH LLC ENCOURAGES GENEDX HOLDINGS CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

15 days ago - By: Investor's Business Daily - Mentions: OPCH

Option Care Health Bring Home Hefty Share Price Gains; Earns RS Rating Upgrade

22 days ago - By: The Motley Fool - Mentions: TDOC ORCL BHVN ARDX ...

Is Teladoc Stock a Buy After Oracle Investment Management Upped Its Stake?

23 days ago - By: Benzinga - Mentions: CAH ELAN GH MEDP ...

6 Healthcare Stocks With Strong Upward Momentum

a month ago - By: GeneDx

GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting

a month ago - By: GeneDx

GeneDx to Participate in Upcoming Investor Conferences

a month ago - By: Benzinga

What Does the Market Think About GeneDx Holdings Corp?

a month ago - By: GeneDx

GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights

2 months ago - By: Schubert Jonckheer & Kolbe LLP

GeneDx Holdings Corp. (NASDAQ: WGS) Investor Reminder: Schubert Jonckheer Investigating Possible False Claims

2 months ago - By: Halper Sadeh LLC

Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights

2 months ago - By: GeneDx

GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025

2 months ago - By: GeneDx

GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx™ and GenomeDx™ Testing

2 months ago - By: Illumina, Inc. - Mentions: ILMN

Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot

2 months ago - By: GeneDx

GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer

2 months ago - By: GeneDx

GeneDx to Partner with Florida’s Sunshine Genetics Network, Launching Nation’s First State-Backed Genomic Newborn Screening Program

2 months ago - By: GeneDx

GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program

2 months ago - By: GeneDx

GeneDx to Showcase Pioneering Research Findings at American Society of Human Genetics (ASHG) Annual Meeting

2 months ago - By: GeneDx

GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025

2 months ago - By: GeneDx

GeneDx Announces First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award

2 months ago - By: GeneDx

GeneDx Appoints Lisa Gurry as Chief Business Officer to Unlock Data and Information Growth

3 months ago - By: GeneDx

GENEDX HOLDINGS CORP (WGS) Stock News

WGS Latest News, Press Relases and Analysis

GeneDX CEO Sells 2,158 Shares After 84% One-Year Bump

HALPER SADEH LLC ENCOURAGES GENEDX HOLDINGS CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Option Care Health Bring Home Hefty Share Price Gains; Earns RS Rating Upgrade

Is Teladoc Stock a Buy After Oracle Investment Management Upped Its Stake?

6 Healthcare Stocks With Strong Upward Momentum

GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting

GeneDx to Participate in Upcoming Investor Conferences

What Does the Market Think About GeneDx Holdings Corp?

GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights

GeneDx Holdings Corp. (NASDAQ: WGS) Investor Reminder: Schubert Jonckheer Investigating Possible False Claims

Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights

GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025

GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx™ and GenomeDx™ Testing

Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot

GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer

GeneDx to Partner with Florida’s Sunshine Genetics Network, Launching Nation’s First State-Backed Genomic Newborn Screening Program

GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program

GeneDx to Showcase Pioneering Research Findings at American Society of Human Genetics (ASHG) Annual Meeting

GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025

GeneDx Announces First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award

GeneDx Appoints Lisa Gurry as Chief Business Officer to Unlock Data and Information Growth

GeneDx Infinity™ Pioneers a New Era of Genetic Medicine with its Introduction at the American Academy of Pediatrics National Conference